An Integrated Platform for Fully Automated, Continuous, & Real-Time Multi-Attributes Monitoring of Upstream Processes for Glycosylated Monoclonal Antibodies Production
Commercial Deployment of Integrated PAT Technologies to Enable Continuous Upstream Production of Glycosylated Monoclonal Antibodies
Evaluation of next generation sequencing (NGS) as a rapid, alternative assay for in vivo and in vitro adventitious virus testing for vaccine safety
Developing Directive Documents for Adoption of the NISTCHO Cell Line for Biomanufacturing Workforce Training
Continuous Countercurrent Spiral Chromatography (CCSC) – Feasibility, Demonstration and Commercialization